Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep830 | Reproductive and Developmental Endocrinology | ECE2020

Anti-müllerian hormone (AMH) as the primary marker for ovarian reserve in transgender male, with or without pcos, under cronic testosterone treatment

Modrego Pardo Ines , Gómez Balaguer Marcelino , Garzón Pastor Sandra , Morillas Ariño Carlos

Background: AMH represents a marker of ovarian reserve and is used in monitoring the effects of gonadotoxic drugs. In PCOS is higher and is an indirect marker of hyperandrogenism. In transsexual man(TM), high prevalence of PCOS is described and AMH provide information about ovarian reserve after exposure to testosterone.Objective: To assess the prevalence of PCOS in young TM previously to testosterone treatment, study the evolution of AMH levels and diff...